Laura Stoppel - Jun 30, 2021 Form 3 Insider Report for Acumen Pharmaceuticals, Inc. (ABOS)

Role
Director
Signature
/s/ Katherine Denby, Attorney-in-Fact
Stock symbol
ABOS
Transactions as of
Jun 30, 2021
Transactions value $
$0
Form type
3
Date filed
6/30/2021, 07:01 PM
Next filing
Jun 17, 2022

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney No Table I or Table II securities beneficially owned